Natalie Birnbaum, Of Counsel at Nelson Hardiman, LLP and founder and attorney at Repro Solutions, P.C., joins “Forbes Newsroom” to discuss the Supreme Court case that could see Mifepristone’s FDA approval overturned, the continued attempt to roll back reproductive rights in the courtroom, and more.
Posted on March 28, 2024
Recent Posts
Cracking the Whip: The FTC’s Clampdown on Healthcare MarketingHacking and Healing: Nation-States, Cyber Attacks, and Healthcare LawHIPAA applies to 3 categories of individuals/entities:Reproductive Rights Attorney: This Is Why Right-Wing Interest Are Attempting To Ban MifepristoneHIPAA applies to 3 categories of individuals/entities:
Related Attorneys
Natalie Birnbaum